Volume 58, Issue 33 pp. 11385-11389
Communication

The Proteome-Wide Potential for Reversible Covalency at Cysteine

Kristine Senkane

Kristine Senkane

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037 USA

Search for more papers by this author
Dr. Ekaterina V. Vinogradova

Corresponding Author

Dr. Ekaterina V. Vinogradova

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037 USA

Search for more papers by this author
Dr. Radu M. Suciu

Dr. Radu M. Suciu

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037 USA

Search for more papers by this author
Dr. Vincent M. Crowley

Dr. Vincent M. Crowley

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037 USA

Search for more papers by this author
Dr. Balyn W. Zaro

Dr. Balyn W. Zaro

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037 USA

Search for more papers by this author
Dr. J. Michael Bradshaw

Dr. J. Michael Bradshaw

Principia Biopharma, 220 E. Grand Avenue, South San Francisco, CA, 94080 USA

Search for more papers by this author
Dr. Ken A. Brameld

Dr. Ken A. Brameld

Principia Biopharma, 220 E. Grand Avenue, South San Francisco, CA, 94080 USA

Search for more papers by this author
Prof. Dr. Benjamin F. Cravatt

Corresponding Author

Prof. Dr. Benjamin F. Cravatt

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, 92037 USA

Search for more papers by this author
First published: 20 June 2019
Citations: 43

Graphical Abstract

A chemical proteomic platform that integrates gel filtration with activity-based protein profiling (ABPP) provides a method to assess small-molecule electrophiles for reversible versus irreversible interactions with cysteine residues in native biological systems, revealing the broad potential for reversible covalency as a strategy for chemical-probe discovery.

Abstract

Reversible covalency, achieved with, for instance, highly electron-deficient olefins, offers a compelling strategy to design chemical probes and drugs that benefit from the sustained target engagement afforded by irreversible compounds, while avoiding permanent protein modification. Reversible covalency has mainly been evaluated for cysteine residues in individual kinases and the broader potential for this strategy to engage cysteines across the proteome remains unexplored. Herein, we describe a mass-spectrometry-based platform that integrates gel filtration with activity-based protein profiling to assess cysteine residues across the human proteome for both irreversible and reversible interactions with small-molecule electrophiles. Using this method, we identify numerous cysteine residues from diverse protein classes that are reversibly engaged by cyanoacrylamide fragment electrophiles, revealing the broad potential for reversible covalency as a strategy for chemical-probe discovery.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.